Clinical Trials Logo

Anemia, Kidney Disease, Chronic clinical trials

View clinical trials related to Anemia, Kidney Disease, Chronic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01519947 Completed - Clinical trials for Anemia, Kidney Disease, Chronic

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis

ALTITUD
Start date: May 30, 2012
Phase: Phase 4
Study type: Interventional

This comparative, open-label, multicenter, parallel-group study evaluated the effect of altitude on the dose requirements of Mircera (methoxy polyethylene glycol-epoetin beta) to achieve a target hemoglobin concentration of 11-12 grams per deciliter (g/dL) in participants with chronic renal anemia in pre-dialysis and dialysis. Four groups of participants, at sea level (below 50 meters) or an altitude above 1800 meters, and pre-dialysis or dialysis, received 50-250 micrograms (mcg) Mircera subcutaneously (SC), according to the local prescribing label.

NCT ID: NCT01422824 Completed - Clinical trials for Anemia, Kidney Disease, Chronic

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis

Start date: June 2010
Phase: N/A
Study type: Observational

This prospective observational study will evaluate the safety and efficacy of Mircera (methoxy polyethylene glycol-epoetin beta) in patients with chronic renal anemia on haemodialysis in maintenance ESA treatment. Data will be collected from patients receiving once monthly Mircera according to standard of care and local labelling during 12 months of treatment.

NCT ID: NCT01379963 Completed - Clinical trials for Anemia, Kidney Disease, Chronic

A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)

Start date: April 2009
Phase: N/A
Study type: Observational

This retrospective observational study will evaluate the hemoglobin levels in patients with renal anemia over 6 months treatment with Mircera (methoxy polyethylene glycol-epoetin beta).

NCT ID: NCT01309295 Completed - Clinical trials for Anemia, Kidney Disease, Chronic

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis

Start date: November 2010
Phase: N/A
Study type: Observational

This prospective observational study will assess the efficacy and safety of Mircera (methoxy polyethylene glycol-epoetin beta) in clinical practice in patients with chronic kidney disease, in pre-dialysis or on dialysis, initiated on Mircera treatment. Data from each patient will be collected over 12 months of treatment.